JewishStatusOpen the app

Kol Haolam · Sep 20, 2026

Kol Haolam — photo status

WSJ: Patients are suing GLP-1 drugmakers over the risk of sudden vision loss. The little-discussed potential risk of popular diabetes and weight-loss drugs is on warning labels outside of the US.

WSJ: Patients are suing GLP-1 drugmakers over the risk of sudden vision loss. The little-discussed potential risk of popular diabetes and weight-loss drugs is on warning labels outside of the US.

Watch in the app All of Kol Haolam's statuses

More from Kol Haolam